Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.06
LHCG's Cash to Debt is ranked lower than
82% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. LHCG: 0.06 )
Ranked among companies with meaningful Cash to Debt only.
LHCG' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.54 Max: No Debt
Current: 0.06
Equity to Asset 0.62
LHCG's Equity to Asset is ranked higher than
74% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. LHCG: 0.62 )
Ranked among companies with meaningful Equity to Asset only.
LHCG' s Equity to Asset Range Over the Past 10 Years
Min: 0.34  Med: 0.72 Max: 0.82
Current: 0.62
0.34
0.82
Interest Coverage 25.87
LHCG's Interest Coverage is ranked higher than
72% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 6.13 vs. LHCG: 25.87 )
Ranked among companies with meaningful Interest Coverage only.
LHCG' s Interest Coverage Range Over the Past 10 Years
Min: 18.3  Med: 102.82 Max: 713.45
Current: 25.87
18.3
713.45
F-Score: 5
Z-Score: 4.71
M-Score: -2.57
WACC vs ROIC
6.28%
10.99%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 8.08
LHCG's Operating margin (%) is ranked higher than
54% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 7.16 vs. LHCG: 8.08 )
Ranked among companies with meaningful Operating margin (%) only.
LHCG' s Operating margin (%) Range Over the Past 10 Years
Min: -1.01  Med: 10.75 Max: 15.99
Current: 8.08
-1.01
15.99
Net-margin (%) 3.93
LHCG's Net-margin (%) is ranked lower than
55% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 4.96 vs. LHCG: 3.93 )
Ranked among companies with meaningful Net-margin (%) only.
LHCG' s Net-margin (%) Range Over the Past 10 Years
Min: -2.09  Med: 5.44 Max: 10.87
Current: 3.93
-2.09
10.87
ROE (%) 9.62
LHCG's ROE (%) is ranked higher than
51% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 9.61 vs. LHCG: 9.62 )
Ranked among companies with meaningful ROE (%) only.
LHCG' s ROE (%) Range Over the Past 10 Years
Min: -4.93  Med: 12.55 Max: 29.05
Current: 9.62
-4.93
29.05
ROA (%) 6.11
LHCG's ROA (%) is ranked higher than
62% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 3.86 vs. LHCG: 6.11 )
Ranked among companies with meaningful ROA (%) only.
LHCG' s ROA (%) Range Over the Past 10 Years
Min: -3.51  Med: 9.49 Max: 20.98
Current: 6.11
-3.51
20.98
ROC (Joel Greenblatt) (%) 68.38
LHCG's ROC (Joel Greenblatt) (%) is ranked higher than
82% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 18.36 vs. LHCG: 68.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
LHCG' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -4.82  Med: 63.16 Max: 147.21
Current: 68.38
-4.82
147.21
Revenue Growth (3Y)(%) 9.30
LHCG's Revenue Growth (3Y)(%) is ranked higher than
61% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. LHCG: 9.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
LHCG' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 3.3  Med: 21.40 Max: 63.8
Current: 9.3
3.3
63.8
EBITDA Growth (3Y)(%) 8.80
LHCG's EBITDA Growth (3Y)(%) is ranked higher than
59% of the 147 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. LHCG: 8.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
LHCG' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -64.8  Med: 27.95 Max: 171.3
Current: 8.8
-64.8
171.3
EPS Growth (3Y)(%) 6.30
LHCG's EPS Growth (3Y)(%) is ranked lower than
52% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. LHCG: 6.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
LHCG' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -21.3  Med: 28.65 Max: 106.5
Current: 6.3
-21.3
106.5
» LHCG's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-06)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

LHCG Guru Trades in Q2 2015

Chuck Royce 1,100 sh (New)
Jim Simons 91,200 sh (-35.41%)
» More
Q3 2015

LHCG Guru Trades in Q3 2015

Joel Greenblatt 83,594 sh (New)
Jim Simons 151,600 sh (+66.23%)
Chuck Royce 1,100 sh (unchged)
» More
Q4 2015

LHCG Guru Trades in Q4 2015

Steven Cohen 75,600 sh (New)
Jim Simons 209,300 sh (+38.06%)
Chuck Royce Sold Out
Joel Greenblatt 52,320 sh (-37.41%)
» More
Q1 2016

LHCG Guru Trades in Q1 2016

Paul Tudor Jones 9,200 sh (New)
Jim Simons 299,500 sh (+43.10%)
Steven Cohen 42,100 sh (-44.31%)
Joel Greenblatt 11,887 sh (-77.28%)
» More
» Details

Insider Trades

Latest Guru Trades with LHCG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NAS:PAHC, NAS:SGRY, NYSE:USPH, NAS:PRSC, OTCPK:COLRF, OTCPK:NKNIF, NYSE:AAC, NYSE:ADPT, OTCPK:MFCSF, NAS:AFAM, NAS:HWAY, NAS:ADUS, NAS:USMD, AMEX:HLTH, NAS:BIOS, NYSE:CCM, OTCPK:CMBGF, NAS:IPCM, NYSE:SEM, OTCPK:FDNH » details
Traded in other countries:LH6.Germany,
LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals.

LHC Group Inc was incorporated on February 9, 2005. The Company provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals (LTACHs). The Company through its wholly- and majority-owned subsidiaries, equity joint ventures and controlled affiliates, operates in 30 states within the continental United States. The Company operates in three segments: home-based services, hospice services and facility-based services. In the home-based services segment, the Company provides home-based post-acute health care services through its home nursing and community-based agencies. Its service locations offer services, including skilled nursing, community-based nursing and companion services, non-skilled community-based services (CBS), medically-oriented social services and physical, occupational and speech therapy. The hospices segment provides end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors and volunteers. It offers services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The LTACH locations provide services to patients with complex medical conditions who have transitioned out of a hospital intensive care unit but whose conditions remain too severe for treatment in a non-acute setting. The Company is subject to federal, state and local laws, which significantly affects its business.

Ratios

vs
industry
vs
history
P/E(ttm) 22.21
LHCG's P/E(ttm) is ranked higher than
58% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 24.56 vs. LHCG: 22.21 )
Ranked among companies with meaningful P/E(ttm) only.
LHCG' s P/E(ttm) Range Over the Past 10 Years
Min: 6.45  Med: 18.36 Max: 33.22
Current: 22.21
6.45
33.22
Forward P/E 21.51
LHCG's Forward P/E is ranked lower than
66% of the 73 Companies
in the Global Medical Care industry.

( Industry Median: 19.12 vs. LHCG: 21.51 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 22.21
LHCG's PE(NRI) is ranked higher than
60% of the 182 Companies
in the Global Medical Care industry.

( Industry Median: 25.00 vs. LHCG: 22.21 )
Ranked among companies with meaningful PE(NRI) only.
LHCG' s PE(NRI) Range Over the Past 10 Years
Min: 6.38  Med: 18.07 Max: 32.35
Current: 22.21
6.38
32.35
Price/Owner Earnings (ttm) 61.71
LHCG's Price/Owner Earnings (ttm) is ranked lower than
81% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 27.59 vs. LHCG: 61.71 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
LHCG' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.64  Med: 18.69 Max: 74.26
Current: 61.71
6.64
74.26
P/B 2.07
LHCG's P/B is ranked higher than
58% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 2.44 vs. LHCG: 2.07 )
Ranked among companies with meaningful P/B only.
LHCG' s P/B Range Over the Past 10 Years
Min: 0.88  Med: 2.01 Max: 4.66
Current: 2.07
0.88
4.66
P/S 0.86
LHCG's P/S is ranked higher than
68% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. LHCG: 0.86 )
Ranked among companies with meaningful P/S only.
LHCG' s P/S Range Over the Past 10 Years
Min: 0.35  Med: 0.87 Max: 2.33
Current: 0.86
0.35
2.33
PFCF 17.80
LHCG's PFCF is ranked higher than
54% of the 112 Companies
in the Global Medical Care industry.

( Industry Median: 19.65 vs. LHCG: 17.80 )
Ranked among companies with meaningful PFCF only.
LHCG' s PFCF Range Over the Past 10 Years
Min: 3.89  Med: 12.37 Max: 91.68
Current: 17.8
3.89
91.68
POCF 13.59
LHCG's POCF is ranked higher than
52% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 13.50 vs. LHCG: 13.59 )
Ranked among companies with meaningful POCF only.
LHCG' s POCF Range Over the Past 10 Years
Min: 3.67  Med: 10.02 Max: 146.83
Current: 13.59
3.67
146.83
EV-to-EBIT 12.45
LHCG's EV-to-EBIT is ranked higher than
76% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 18.79 vs. LHCG: 12.45 )
Ranked among companies with meaningful EV-to-EBIT only.
LHCG' s EV-to-EBIT Range Over the Past 10 Years
Min: -80.8  Med: 9.40 Max: 94.9
Current: 12.45
-80.8
94.9
EV-to-EBITDA 10.54
LHCG's EV-to-EBITDA is ranked higher than
65% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 13.06 vs. LHCG: 10.54 )
Ranked among companies with meaningful EV-to-EBITDA only.
LHCG' s EV-to-EBITDA Range Over the Past 10 Years
Min: -74.8  Med: 8.80 Max: 137.5
Current: 10.54
-74.8
137.5
PEG 0.89
LHCG's PEG is ranked higher than
84% of the 79 Companies
in the Global Medical Care industry.

( Industry Median: 2.79 vs. LHCG: 0.89 )
Ranked among companies with meaningful PEG only.
LHCG' s PEG Range Over the Past 10 Years
Min: 0.2  Med: 0.36 Max: 0.61
Current: 0.89
0.2
0.61
Shiller P/E 25.51
LHCG's Shiller P/E is ranked higher than
53% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 26.59 vs. LHCG: 25.51 )
Ranked among companies with meaningful Shiller P/E only.
LHCG' s Shiller P/E Range Over the Past 10 Years
Min: 13.44  Med: 20.46 Max: 32.56
Current: 25.51
13.44
32.56
Current Ratio 1.80
LHCG's Current Ratio is ranked higher than
71% of the 229 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. LHCG: 1.80 )
Ranked among companies with meaningful Current Ratio only.
LHCG' s Current Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.19 Max: 4.45
Current: 1.8
1.65
4.45
Quick Ratio 1.80
LHCG's Quick Ratio is ranked higher than
74% of the 229 Companies
in the Global Medical Care industry.

( Industry Median: 1.23 vs. LHCG: 1.80 )
Ranked among companies with meaningful Quick Ratio only.
LHCG' s Quick Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.19 Max: 4.45
Current: 1.8
1.65
4.45
Days Sales Outstanding 50.82
LHCG's Days Sales Outstanding is ranked lower than
61% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 42.74 vs. LHCG: 50.82 )
Ranked among companies with meaningful Days Sales Outstanding only.
LHCG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.01  Med: 50.41 Max: 85.77
Current: 50.82
46.01
85.77

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.14
LHCG's Price/Projected FCF is ranked higher than
70% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. LHCG: 1.14 )
Ranked among companies with meaningful Price/Projected FCF only.
LHCG' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.34  Med: 0.55 Max: 1.19
Current: 1.14
0.34
1.19
Price/Median PS Value 1.00
LHCG's Price/Median PS Value is ranked higher than
59% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. LHCG: 1.00 )
Ranked among companies with meaningful Price/Median PS Value only.
LHCG' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.42  Med: 1.00 Max: 2.67
Current: 1
0.42
2.67
Earnings Yield (Greenblatt) (%) 8.01
LHCG's Earnings Yield (Greenblatt) (%) is ranked higher than
82% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. LHCG: 8.01 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
LHCG' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.1  Med: 10.10 Max: 25.9
Current: 8.01
1.1
25.9
Forward Rate of Return (Yacktman) (%) -17.30
LHCG's Forward Rate of Return (Yacktman) (%) is ranked lower than
92% of the 104 Companies
in the Global Medical Care industry.

( Industry Median: 10.07 vs. LHCG: -17.30 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
LHCG' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -11.6  Med: 13.60 Max: 28946.6
Current: -17.3
-11.6
28946.6

More Statistics

Revenue (TTM) (Mil) $845.8
EPS (TTM) $ 1.89
Beta0.69
Short Percentage of Float2.00%
52-Week Range $32.77 - 51.83
Shares Outstanding (Mil)18.12

Analyst Estimate

Dec16 Dec17
Revenue (Mil $) 909 958
EPS ($) 1.96 2.18
EPS w/o NRI ($) 1.96 2.18
EPS Growth Rate
(3Y to 5Y Estimate)
15.00%
» More Articles for LHCG

Headlines

Articles On GuruFocus.com
Intelligent (and Unintelligent) Investing: Part 1 Jun 03 2015 
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
LHC Group Reports Operating Results (10-K) Mar 10 2011 
LHC Group Reports Operating Results (10-Q) Nov 03 2010 
LHC Group Reports Operating Results (10-Q) Aug 06 2010 
LHC Group (LHCG) CFO Peter J. Roman sells 1,200 Shares May 27 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 169,800 Shares May 13 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 5,200 Shares May 12 2010 
A Simple Metric to Clarify the Balance Sheet Apr 19 2010 
2009 Forbes 200 Best Small Companies (Part I): Lumber Liquidators, Allegiant Travel, Quality Systems Nov 11 2009 

More From Other Websites
ETF’s with exposure to LHC Group, Inc. : June 20, 2016 Jun 20 2016
LHC Group, Inc. :LHCG-US: Earnings Analysis: Q1, 2016 By the Numbers : June 7, 2016 Jun 07 2016
LHC Group announces two definitive purchase agreements for home health, hospice and community based... Jun 07 2016
LHC Group Announces Two Definitive Purchase Agreements for Home Health, Hospice and Community Based... Jun 07 2016
BioScrip (BIOS) in Focus: Stock Adds 8.4% in Session Jun 07 2016
LHC GROUP, INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters... Jun 03 2016
LHC Group to present at the Jefferies 2016 Healthcare Conference Jun 02 2016
LHC Group to Present at the Jefferies 2016 Healthcare Conference Jun 02 2016
Massive Insider Selling at Apple Inc. (AAPL) & LHC Group Inc. (LHCG), Plus 3 Companies with Notable... May 26 2016
Will LHC Group (LHCG) Crush Estimates at Its Next Earnings Report? May 20 2016
LHC Group to present at the UBS Global Healthcare Conference May 19 2016
LHC Group to Present at the UBS Global Healthcare Conference May 18 2016
LHC GROUP, INC Financials May 12 2016
Edited Transcript of LHCG earnings conference call or presentation 5-May-16 3:00pm GMT May 06 2016
LHC GROUP, INC Files SEC form 10-Q, Quarterly Report May 05 2016
LHC Group announces earnings per diluted share of $0.44 for first quarter 2016, up 12.8% from first... May 05 2016
LHC Group announces earnings per diluted share of $0.44 for first quarter 2016, up 12.8% from first... May 05 2016
LHC Group Inc Earnings Call scheduled for 11:00 am ET today May 05 2016
LHC GROUP, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 04 2016
LHC Group Announces Earnings Per Diluted Share of $0.44 for First Quarter 2016, Up 12.8% From First... May 04 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)